KRAS and BRAF Mutation Rates and Survival Outcomes in Colorectal Cancer in an Ethnically Diverse Patient Cohort
Paul Habashy(South Western Sydney Local Health District), Cheok Soon Lee(Liverpool Hospital), Tristan Rutland(Liverpool Hospital), Xiaojuan Wu(Liverpool Hospital), Weng Ng(Sir Run Run Shaw Hospital), Vivienne Lea(Liverpool Hospital), Stephanie Lim(Camden and Campbelltown Hospitals), Tara L. Roberts(Camden and Campbelltown Hospitals), Therese M. Becker(Liverpool Hospital), Wei Chua(Liverpool Hospital), Wendy A. Cooper(The University of Sydney), Scott M. MacKenzie(Liverpool Hospital), Ruta Gupta(Cedars-Sinai Medical Center), Kate Wilkinson(Liverpool Hospital), Bin Wang(Hebei Medical University), Joseph Descallar(UNSW Sydney), Mark Lee, Joseph W. Po(Camden and Campbelltown Hospitals)
Cited by 12
Related Papers
HIN-200 Proteins Regulate Caspase Activation in Response to Foreign Cytoplasmic DNA
|Science|2009|822
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
|The Lancet Oncology|2023|663
AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC
|Cell Death and Differentiation|2013|507
The mammalian PYHIN gene family: Phylogeny, evolution and expression
|BMC Evolutionary Biology|2012|202
The Molecular Basis for the Lack of Immunostimulatory Activity of Vertebrate DNA
|The Journal of Immunology|2003|174